Sienna Biopharmaceuticals, Inc.

SNNAQ · OTC
Analyze with AI
9/30/2019
6/30/2019
3/31/2019
12/31/2018
Operating Activities
Net Income-$4-$8-$16-$19
Dep. & Amort.$0$0$0$0
Deferred Tax$26$0$0$0
Stock-Based Comp.$1$1$2$1
Change in WC-$8-$1-$3-$2
Other Non-Cash-$33$0$5$4
Operating Cash Flow-$18-$8-$13-$16
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$21$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$20$0-$0$0
Financing Cash Flow-$20$0$21$0
Forex Effect$0$0-$0-$0
Net Chg. in Cash-$38-$8$9-$15
Supplemental Information
Beg. Cash$49$57$49$64
End Cash$12$49$57$49
Free Cash Flow-$18-$8-$13-$16
Sienna Biopharmaceuticals, Inc. (SNNAQ) Financial Statements & Key Stats | AlphaPilot